These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 29773575)

  • 1. Measuring Physical Activity With Implanted Cardiac Devices: A Systematic Review.
    Rosman L; Lampert R; Sears SF; Burg MM
    J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29773575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical Activity Measured by Implanted Devices Predicts Atrial Arrhythmias and Patient Outcome: Results of IMPLANTED (Italian Multicentre Observational Registry on Patients With Implantable Devices Remotely Monitored).
    Palmisano P; Guerra F; Ammendola E; Ziacchi M; Luigi Pisanò EC; Dell'Era G; Aspromonte V; Zaccaria M; Di Ubaldo F; Capucci A; Nigro G; Occhetta E; Maglia G; Ricci RP; Boriani G; Accogli M;
    J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29478022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of COVID-19 lockdown in patients with implantable cardioverter and cardiac resynchronization therapy defibrillators: insights from daily remote monitoring transmissions.
    Mascioli G; Lucca E; Napoli P; Giacopelli D
    Heart Vessels; 2021 Nov; 36(11):1694-1700. PubMed ID: 33779824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation and reimbursement of remote monitoring for cardiac implantable electronic devices in Europe: a survey from the health economics committee of the European Heart Rhythm Association.
    Mairesse GH; Braunschweig F; Klersy K; Cowie MR; Leyva F
    Europace; 2015 May; 17(5):814-8. PubMed ID: 25713012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
    Khazanie P; Greiner MA; Al-Khatib SM; Piccini JP; Turakhia MP; Varosy PD; Masoudi FA; Curtis LH; Hernandez AF;
    Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27296396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Battery longevity in cardiac resynchronization therapy implantable cardioverter defibrillators.
    Alam MB; Munir MB; Rattan R; Flanigan S; Adelstein E; Jain S; Saba S
    Europace; 2014 Feb; 16(2):246-51. PubMed ID: 24099864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of inappropriate anti-tachycardia pacing therapies and shocks by a novel suite of detection algorithms in heart failure patients with cardiac resynchronization therapy defibrillators: a historical comparison of a prospective database.
    Lunati M; Proclemer A; Boriani G; Landolina M; Locati E; Rordorf R; Daleffe E; Ricci RP; Catanzariti D; Tomasi L; Gulizia M; Baccillieri MS; Molon G; Gasparini M;
    Europace; 2016 Sep; 18(9):1391-8. PubMed ID: 26826135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mobile health and implantable cardiac devices: Patients' expectations.
    Villani GQ; Villani A; Zanni A; Sticozzi C; Maceda DP; Rossi L; Pisati MS; Piepoli MF
    Eur J Prev Cardiol; 2019 Jun; 26(9):920-927. PubMed ID: 30823864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon.
    Boriani G; Braunschweig F; Deharo JC; Leyva F; Lubinski A; Lazzaro C
    Europace; 2013 Oct; 15(10):1453-62. PubMed ID: 23696624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complications in recipients of cardioverter-defibrillator or cardiac resynchronization therapy: Insights from Silesian Center Defibrillator registry.
    Tajstra M; Gadula-Gacek E; Kurek A; Adamowicz-Czoch E; Olszowski D; Ostręga M; Ciślak A; Pyka Ł; Hawranek M; Lekston A; Poloński L; Gąsior M
    Cardiol J; 2017; 24(5):515-522. PubMed ID: 27734455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Battery longevity of implantable cardioverter-defibrillators and cardiac resynchronization therapy defibrillators: technical, clinical and economic aspects. An expert review paper from EHRA.
    Boriani G; Merino J; Wright DJ; Gadler F; Schaer B; Landolina M
    Europace; 2018 Dec; 20(12):1882-1897. PubMed ID: 29757390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. INvestigation on Routine Follow-up in CONgestive HearT FAilure Patients with Remotely Monitored Implanted Cardioverter Defibrillators SysTems (InContact).
    Hansen C; Loges C; Seidl K; Eberhardt F; Tröster H; Petrov K; Grönefeld G; Bramlage P; Birkenhauer F; Weiss C
    BMC Cardiovasc Disord; 2018 Jun; 18(1):131. PubMed ID: 29954340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.
    Biton Y; Zareba W; Goldenberg I; Klein H; McNitt S; Polonsky B; Moss AJ; Kutyifa V;
    J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remote monitoring of cardiac implantable electronic devices (CIED).
    Zeitler EP; Piccini JP
    Trends Cardiovasc Med; 2016 Aug; 26(6):568-77. PubMed ID: 27134007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applicability of a risk score for prediction of the long-term benefit of the implantable cardioverter defibrillator in patients receiving cardiac resynchronization therapy.
    Barra S; Looi KL; Gajendragadkar PR; Khan FZ; Virdee M; Agarwal S
    Europace; 2016 Aug; 18(8):1187-93. PubMed ID: 26566940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantable Cardiovascular Devices: Current and Emerging Technologies for Remote Heart Failure Monitoring.
    Gill J
    Cardiol Rev; 2023 May-Jun 01; 31(3):128-138. PubMed ID: 35349243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Implantable Device Measured Physical Activity With Hospitalization for Heart Failure.
    Kelly JP; Ballew NG; Lin L; Hammill BG; Stivland TM; Jones PW; Curtis LH; Hernandez AF; Greiner MA; Atwater BD
    JACC Heart Fail; 2020 Apr; 8(4):280-288. PubMed ID: 32035894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Battery drain in daily practice and medium-term projections on longevity of cardioverter-defibrillators: an analysis from a remote monitoring database.
    Boriani G; Ritter P; Biffi M; Ziacchi M; Diemberger I; Martignani C; Valzania C; Valsecchi S; Padeletti L; Gadler F
    Europace; 2016 Sep; 18(9):1366-73. PubMed ID: 26847076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An individualized left ventricular lead-targeting strategy improves long-term survival of cardiac resynchronization therapy patients and influences the benefit of the implantable cardioverter-defibrillator: a long-term follow-up of the TARGET study.
    Barra S; Yu E; Khan F; Dutka D; Virdee M
    J Cardiovasc Med (Hagerstown); 2017 Jul; 18(7):553-555. PubMed ID: 27136703
    [No Abstract]   [Full Text] [Related]  

  • 20. Incremental benefit of cardiac resynchronisation therapy with versus without a defibrillator.
    Martens P; Verbrugge FH; Nijst P; Dupont M; Nuyens D; Herendael HV; Rivero-Ayerza M; Tang WH; Mullens W
    Heart; 2017 Dec; 103(24):1977-1984. PubMed ID: 28716973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.